How gene therapies are changing the Qualified Person role in the EU
As products grow more complex and regulation races to catch up, QPs are continuously stress‑testing each stage – from starting material to the final syringe – to balance innovation with uncompromising patient safety. Sharp Clinical’s Mike Jentsch explains how this is reshaping their approach to risk assessment and regulatory oversight.
